AVEFF (Avecho Biotechnology) Change In Other Working Capital : $0.00 Mil (TTM As of Dec. 2024)

View and export this data going back to 2006. Start your Free Trial

What is Avecho Biotechnology Change In Other Working Capital?

Avecho Biotechnology's Change In Other Working Capital for the quarter that ended in Dec. 2024 was $0.00 Mil. It means Avecho Biotechnology's Other Working Capital stayed the same from Jun. 2024 to Dec. 2024 .

Avecho Biotechnology's Change In Other Working Capital for the fiscal year that ended in Dec. 2024 was $0.00 Mil. It means Avecho Biotechnology's Other Working Capital stayed the same from Dec. 2023 to Dec. 2024 .

Avecho Biotechnology Change In Other Working Capital Historical Data

The historical data trend for Avecho Biotechnology's Change In Other Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avecho Biotechnology Change In Other Working Capital Chart

Avecho Biotechnology Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Change In Other Working Capital

Get a 7-Day Free Trial

Avecho Biotechnology Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Change In Other Working Capital	Get a 7-Day Free Trial															-	-	-	-	-

Avecho Biotechnology Change In Other Working Capital Calculation

Change In Other Working Capital is any increase or decrease between periods of other working capital that are not otherwise classified.

Change In Other Working Capital for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.00 Mil.

Avecho Biotechnology Change In Other Working Capital Related Terms

Thank you for viewing the detailed overview of Avecho Biotechnology's Change In Other Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Avecho Biotechnology Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Avecho Biotechnology Ltd (OTCPK:AVEFF) » Definitions » Change In Other Working Capital

Comparable Companies

Traded in Other Exchanges

OEZ:Germany AVE:Australia

Address

Unit A8, 2A Westall Road, Clayton, Melbourne, VIC, AUS, 3168

Website

https://www.avecho.com.au

Avecho Biotechnology Ltd is a research-based biotechnology company engaged in the development, production, sales, and licensing of products incorporating its patented platform technology Tocopheryl Phosphate Mixture (TPM), for the pharmaceutical, skincare, and animal health and nutrition industries. Its segments include Production, Human Health, and other segments. The Production segment, which is the key revenue driver, manufactures and sells TPM and Vital ET for use in drug delivery and cosmetic formulations. The Human Health segment's portfolio covers the delivery of drugs through gels, injectables, and patches including the conduct of research and development activities. It focuses on the development of patches, including TPM/Oxymorphone and TPM/Oxycodone.

Avecho Biotechnology Headlines

From GuruFocus

Avecho and Sandoz enter exclusive license and development agreement to commercialise CBD for insomnia in Australia

By PRNewswire • 03-03-2025